JPMorgan Chase is set to report second-quarter earnings – here’s what the Street expects

JPMorgan Chase is set to report second-quarter earnings – here’s what the Street expects


Jamie Dimon, chairman and chief executive officer of JPMorgan Chase & Co., speaks during an Economic Club of New York (ECNY) event in New York, US, on Tuesday, April 23, 2024. 

Victor J. Blue | Bloomberg | Getty Images

JPMorgan Chase is scheduled to report second-quarter earnings before the opening bell Friday.

Here’s what Wall Street expects:

  • Earnings: $4.19 a share, according to LSEG
  • Revenue: $49.9 billion, according to LSEG
  • Net interest income: $22.8 billion, according to StreetAccount
  • Trading Revenue: Fixed income of $4.82 billion; Equities of $2.77 billion, according to StreetAccount

Will cracks in the economy begin to reveal themselves in JPMorgan Chase results?

While JPMorgan has passed numerous stress tests lately — actual and hypothetical — it’s possible the bank’s consumers could begin showing more strain from higher interest rates.

Another open question is about succession at JPMorgan after CEO Jamie Dimon acknowledged in May that he now had less than five years remaining in his current role.

Wells Fargo and Citigroup are scheduled to post results later Friday, while Goldman Sachs, Bank of America and Morgan Stanley report next week.

This story is developing. Please check back for updates.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More